Climaco John M Insider Trades

Insider Trading History

Track insider trading activity for Climaco John M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $41.9k 9,761 shares
Last Trade
Nov 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.4k 9,761 shares
$6.70
$4.29
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $454k 165,169 shares
Last Trade
Nov 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 150,000 shares
$12.19
$2.75
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $41.7k 15,169 shares
Last Trade
Nov 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.5k 10,000 shares
$2.45
$2.75
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $2.4M 559,533 shares
Last Trade
Apr 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12B 166,000 shares
$6,720.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $1.69M 393,533 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.52B 333,332 shares
$7,575.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $925k 215,676 shares
Last Trade
Feb 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.26B 166,666 shares
$7,575.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $210k 49,010 shares
Last Trade
Aug 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$150M 2,750 shares
$54,600.00
$4.29
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $213k 77,501 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.3k 15,000 shares
$0.62
$2.75
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $258k 60,201 shares
Last Trade
Apr 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.6M 1,250 shares
$45,300.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $198k 46,260 shares
Last Trade
Apr 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$56.6M 1,250 shares
$45,300.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $193k 45,010 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$306M 15,000 shares
$20,430.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $264k 61,451 shares
Last Trade
Mar 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$492M 16,467 shares
$29,886.00
$4.29
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $131k 47,501 shares
Last Trade
Jun 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13M 23,333 shares
$558.75
$2.75
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $5.79M 1,349,500 shares
Last Trade
Apr 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180B 600,000 shares
$300,600.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $4.03M 940,298 shares
Last Trade
Mar 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.38B 35,000 shares
$239,400.00
$4.29
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $3.88M 905,298 shares
Last Trade
Nov 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.74B 5,000 shares
$1,147,500.00
$4.29
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $66.5k 24,168 shares
Last Trade
Jun 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8M 10,000 shares
$1,481.25
$2.75
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $3.22M 749,500 shares
Last Trade
Feb 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$937B 310,000 shares
$3,024,000.00
$4.29
Moleculin Biotech
Moleculin Biotech MBRX
Director
Holding Value $234k 85,000 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.8M 15,000 shares
$2,520.00
$2.75
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Executive Officer
Holding Value $3.86M 900,000 shares
Last Trade
Nov 07, 2019 Sale
No data
No data
$4.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up